ngµç×ÓÓÎÏ·

05

¿ÆÑÐÏ£Íû

Á¥ÊôµÚÁùÒ½ÔºÍô½¨Æ½½ÌÊÚÍŶÓÑо¿Ð§¹ûÔÙ´ÎÔÚ¹ú¼Ê¶¥¼¶Ö×ÁöѧÔÓÖ¾JCO½ÒÏþ

ÔĶÁÁ¿£º

½üÆÚ£¬£¬ngµç×ÓÓÎÏ·Á¥ÊôµÚÁùÒ½ÔºÖ±³¦°©ÁªºÏÕïÖÎÖÐÐÄÊ×ϯר¼ÒÍô½¨Æ½½ÌÊÚ×÷ΪͨѶ×÷Õߣ¬£¬Ö×ÁöÄÚ¿ÆÖ÷ÈεËÑÞºì½ÌÊÚ¡¢½áÖ±³¦¸ØÃÅÍâ¿ÆÀ¼Æ½½ÌÊں͸£½¨Ò½¿Æ´óѧÁ¥ÊôЭºÍÒ½Ôº³ØÅϽÌÊÚΪÅäºÏµÚÒ»×÷ÕßÐû²¼ÎÄÕ¡°¸ÄÁ¼mFOLFOX6ÁªºÏ»ò²»ÁªºÏ·ÅÁƱÈÕÕ5-·úÄòà×à¤ÁªºÏ·ÅÁÆÐ¸¨ÖúÖÎÁƾֲ¿Ï£ÍûÆÚÖ±³¦°©£ºÖйúFOWARCÑо¿µÄ×îÖÕЧ¹û¡±¡£¡£ÕâÊǸÃÍŶӵÄÑо¿Ð§¹ûµÚ¶þ´ÎÔÚ¹ú¼Ê×ÅÃûÖ×ÁöѧÆÚ¿¯Journal of Clinical Oncology£¨2018ÄêÓ°ÏìÒò×Ó28.245·Ö£©½ÒÏþ¡£¡£

ÕâÊÇÈ«Çò¹æÄ£ÄÚÊ׸öÒÔËæ»ú±ÈÕÕÑо¿µÄÒªÁì̽Ë÷ÁËÈ«Á¿»¯ÁÆÁªºÏ·ÅÁƺʹ¿´âи¨Öú»¯ÁƵÄÖ±³¦°©ÊõǰÖÎÁƵÄģʽ£¬£¬ÆäЧ¹ûÒԸ߼¶±ðµÄѭ֤ҽѧ֤¾Ý֤ʵȫÁ¿·Å»¯ÁÆ¿ÉÒÔÌá¸ß²¡ÀíÍêÈ«»º½âÂÊ£¬£¬¶ø´¿´âи¨Öú»¯ÁÆÖÎÁƾֲ¿Ï£ÍûÆÚÖ±³¦°©Í¬Ñù¿ÉÒÔµÖ´ïÓëÄ¿½ñ±ê×¼·Å»¯ÁÆÏàËÆµÄ¾Ö²¿¸´·¢ºÍºã¾ÃµÄÉúÑÄ£¬£¬Í¬Ê±ÓиüºÃµÄÉúÑÄÖÊÁ¿£¬£¬ÓÈÆäÊǸüºÃµÄ¸ØÃŹ¦Ð§¡£¡£

¸ÃÑо¿ÎªÖ±³¦°©ÖÎÁÆÁìÓò¿ªÆôÁËÐÂÆªÕ£¬£¬¸»ºñÁËи¨ÖúģʽµÄÑ¡Ôñ£¬£¬¹ØÓÚÌá¸ß»¼ÕßÉúÑÄÖÊÁ¿£¬£¬±£»£»£»¤Æ÷¹Ù¹¦Ð§ÒÔ¼°ÓÅ»¯ºÍ½ÚÔ¼ÎÒ¹úÒ½ÁÆ×ÊÔ´¾ßÓÐÖ÷ÒªÒâÒ壬£¬µÓÚ¨ÁËngµç×ÓÓÎÏ·Á¥ÊôµÚÁùÒ½ÔºÔÚÖ±³¦°©ÕïÁÆÁìÓòµÄÈ«ÇòÁìÏÈְλ¡£¡£

Íô½¨Æ½½ÌÊÚ½éÉÜ£¬£¬FOWARCÑо¿ÊÇÍêÈ«ÓÉÖйúÑо¿Õß×ÔÖ÷Éè¼Æ¡¢Ö´ÐкÍÏàÖúÍê³ÉµÄ´óÐͶàÖÐÐÄ¡¢Ëæ»ú±ÈÕÕÁÙ´²ÊÔÑé¡£¡£ËûÌåÏÖ£¬£¬ÁÙ´²ÉÏ£¬£¬ÎÒ¹ú½áÖ±³¦°©·¢²¡¾ßÓÐÇàÄ껼Õß±ÈÀý¸ß¡¢Ö±³¦°©±ÈÀý¸ßºÍÔçÆÚÕï¶ÏÂʵ͵ÄÌØµã¡£¡£ÏÖÔÚ¹ØÓÚ¿ÉÇгýµÄ¾Ö²¿Ï£ÍûÆÚÖ±³¦°©»¼Õߣ¬£¬Í¨Àý·úÄòà×à¤Í¬²½·Å»¯ÁÆÁªºÏÊÖÊõµÄ×ÛºÏÖÎÁÆÔÚÒ»¶¨³Ì¶ÈÉÏÌá¸ßÁËÖÎÓúÂÊ£¬£¬µ«ÈÔÓÐ30%µÄ»¼Õ߻᷺ÆðÔ¶´¦Æ÷¹Ù×ªÒÆ£¬£¬²¢×îÖÕÍþвÉúÃü¡£¡£

Íô½¨Æ½½ÌÊÚÌåÏÖ£¬£¬¹ØÓڴ󲿷־ֲ¿Ï£ÍûÆÚÖ±³¦°©»¼Õß¶øÑÔ£¬£¬¿ÉÒÔ˼Á¿ÏȽÓÄÉFOLFOX·½°¸»¯ÁÆÈ¡´úͬ²½·Å»¯ÁÆ£¬£¬²¢Æ¾Ö¤ºóÐøÁÆÐ§ÆÀ¹ÀÑ¡ÔñÐÔ×·¼Ó·ÅÁÆ¡£¡£ÉÏÊöÕ½ÂÔµÄÌá³ö¿ªÆôÁËÖ±³¦°©ÖÎÁÆÁìÓòÐÂÆªÕ£¬£¬¹ØÓÚÌá¸ß»¼ÕßÉúÑÄÖÊÁ¿£¬£¬±£»£»£»¤Æ÷¹Ù¹¦Ð§ÒÔ¼°ÓÅ»¯ºÍ½ÚÔ¼ÎÒ¹úÒ½ÁÆ×ÊÔ´¾ßÓÐÖ÷ÒªÒâÒå¡£¡£

Íô½¨Æ½½ÌÊÚÓÚ2011Äêǣͷ²¢ÁªºÏÌìÏÂ15¼Ò¸ßˮƽҽԺÆô¶¯ÁË´ËÏîǰհÐÔ¶àÖÐÐÄËæ»ú±ÈÕÕÁÙ´²Ñо¿FOWARC£¬£¬Ï£Íûͨ¹ýÔöÇ¿ÊõǰϵͳÐÔÒ©ÎïÖÎÁƵִïͬ²½·Å»¯ÁƵÄЧ¹û£¬£¬Í¬Ê±ÎªÍâ¿ÆÊÖÊõ´´Á¢ÏàÒ˵ÄÌõ¼þ£¬£¬´Ó¶ø¸ÄÉÆ»¼ÕßÔ¤ºó£¬£¬½ÚÔ¼Éç»áÒ½ÁÆ×ÊÔ´¡£¡£

¸ÃÑо¿×Ô2011Äê1ÔÂÖÁ2015Äê2Ô£¬£¬¹²Èë×é495Ãû¾Ö²¿Ï£ÍûÆÚÖ±³¦°©»¼Õߣ¬£¬Ëæ»ú·ÖÅäÖÁ5-FU+·ÅÁÆ×飨FU-RT£©£¬£¬mFOLFOX6+·ÅÁÆ£¨FOLFOX-RT£©ºÍ´¿´âmFOLFOX6»¯ÁÆ×飨FOLFOX£©¡£¡£Ö÷ÒªÑо¿ÖÕµãΪ3ÄêµÄÎÞ²¡ÉúÑÄʱ¼ä£¨DFS£©¡£¡£

Ñо¿½üÆÚÁÆÐ§Ð§¹ûÏÔʾÈý×鲡ÀíÍêÈ«»º½âÂÊ£¨PCR£©»®·ÖΪ14.3%¡¢28%ºÍ6.1%£¬£¬¶ø½µÆÚÂÊ£¨Êõºó·ÖÆÚΪ0-IÆÚ£©Îª37.6%¡¢57.4%ºÍ35.8%¡£¡£Ñо¿Ð§¹ûÌáÐÑ£º´¿´âFOLFOX·½°¸Ð¸¨Öú»¯ÁÆÓë5-FUΪ»ù´¡µÄ·Å»¯ÁÆÏà±È£¬£¬¾ßÓÐÏàËÆµÄR0ÇгýÂʺÍÖ×Áö½µÆÚÂÊÒÔ¼°¸üµÍµÄÊÖÊõ²¢·¢Ö¢±¬·¢ÂÊ£¬£¬Ô¼35%»¼Õß½öÊõǰ½ÓÊÜ´¿´â»¯Áƶø²»ÐèÒª·ÅÁÆÒ²ÄܺܺõľÙÐÐÊÖÊõÖÎÁÆ¡£¡£¾ÝÏàʶ£¬£¬´ËÑо¿Á½´ÎÈëÑ¡ÁË2015ÄêºÍ2018ÄêÃÀ¹úÖ×ÁöÁÙ´²Ñ§»á£¨ASCO£©Äê»á¿ÚÍ·±¨¸æ£¬£¬²¢ÓÚ2016Äê9ÔµÚÒ»´ÎÔÚJournal of Clinical Oncology£¨2016 Sep 20;34(27):3300-7.£©ÔÓÖ¾½ÒÏþ¡£¡£

´Ë´ÎÑо¿µÄ3ÄêÎÞ²¡ÉúÑÄÂÊЧ¹ûÏÔʾ,FU-RT×éΪ72.9%£¬£¬FOLFOX-RT×éΪ77.2%£¬£¬FOLFOX×éΪ73.5%¡£¡£Èý×éµÄ3Ä긴·¢ÂʾùСÓÚ10%£¬£¬»®·Ö8.0%¡¢7.0%ºÍ8.3%£¬£¬3ÄêÉúÑÄÂÊΪ91.3%¡¢89.1%ºÍ90.7%¡£¡£Ñо¿Ô¶ÆÚЧ¹ûÔÙ´Î֤ʵ£¬£¬Êõǰ´¿´âFOLFOX·½°¸Ð¸¨Öú»¯ÁÆÔÚ3Äê¾Ö²¿¸´·¢ÂÊ¡¢ÎÞ²¡ÉúÑÄÂÊÒÔ¼°ÉúÑÄÂʵÈÔ¶ÆÚÁÆÐ§Ö¸±ê·½Ãæ¾ùÓëÄ¿½ñµÄ±ê×¼5-FUͬ²½·Å»¯ÁÆÏ൱¡£¡£¶øÇå¾²ÐÔ·½Ã棬£¬´¿´â»¯ÁÆ×黼ÕߵĽüÆÚ²¢·¢Ö¢£¨ÈçÎǺϿÚðü¡¢ÎǺϿÚÏÁÕ­£©ºÍÔ¶ÆÚ²¢·¢Ö¢±¬·¢Âʾù½Ï·ÅÁÆ×éÓÐÏÔÖø½µµÍ¡£¡£Í¬Ê±Ñо¿»¹ÏÔʾ£¬£¬´¿´â»¯ÁÆÔڿرãÄÜÁ¦ºÍ´ó±ã´ÎÊýµÈ¸ØÃŹ¦Ð§·½ÃæµÄÓÐÏÔ×ÅÓÅÊÆ¡£¡£

ÂÛÎÄÁ´½Ó£ºhttp://apps.webofknowledge.com/full_record.do?product=UA&search_mode=GeneralSearch&qid=2&SID=8AGw2PYXH2LQMNzOdPW&page=1&doc=1

¡¾ÍøÕ¾µØÍ¼¡¿